Perrigo | PRGO - Loan Capital


Perrigo reported $3.61B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Abbott USD 9.9B 1.7B Dec/2025
Bayer EUR 32.71B 1B Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Coherus Biosciences USD 294.85M 2.33M Mar/2025
Dr.Reddys Laboratories INR 11.61B 29M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
J&J USD 39.44B 30M Dec/2025
Merck USD 39.97B 6B Sep/2025
Nestle CHF 46.99B 4.71B Jun/2025
Pacira USD 376.72M 1.37M Sep/2025
Perrigo USD 3.61B 7.4M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Reckitt Benckiser GBP 7.24B 590M Dec/2024
Sanofi EUR 15.72B 2.45B Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025
Zoetis USD 9.04B 1.97B Dec/2025